Loading...
XJPX
3391
Market cap6.12bUSD
Oct 09, Last price  
2,123.50JPY
1D
-0.40%
1Q
-5.91%
Jan 2017
-80.87%
IPO
-16.40%
Name

Tsuruha Holdings Inc

Chart & performance

D1W1MN
XJPX:3391 chart
P/E
22.55
P/S
0.66
EPS
94.18
Div yield, %
2.25%
Shrs. gr., 5y
3.99%
Rev. gr., 5y
9.64%
Revenues
1.45t
+35.36%
227,787,323,000251,863,571,000279,763,000,000299,579,000,000320,969,000,000343,019,000,000388,465,000,000440,427,000,000527,508,000,000577,088,000,000673,238,000,000782,447,000,000841,036,000,000919,303,000,000915,700,000,000970,079,000,0001,027,462,000,0001,071,683,418,0001,071,683,418,0001,450,585,000,000
Net income
42.67b
+95.67%
6,256,002,0006,045,896,0006,558,000,0007,881,000,00010,594,000,00013,461,000,00014,563,000,00017,210,000,00019,323,000,00023,233,000,00024,798,000,00024,824,000,00027,900,000,00026,284,000,00021,389,000,00025,259,000,00021,743,000,00021,807,464,00021,807,464,00042,670,000,000
CFO
84.58b
+30.84%
7,111,273,0007,397,514,0009,202,223,00018,982,000,00015,276,000,000387,000,00014,135,000,00013,690,000,00023,788,000,00049,117,000,0003,700,000,00027,199,000,00033,701,000,00040,636,000,00076,459,000,00035,832,000,000804,000,00051,964,000,00064,643,000,00084,582,000,000
Dividend
Feb 25, 202724 JPY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Tsuruha Holdings Inc. is a Japan-based drugstore holding company operating a nationwide chain of retail pharmacies. The company's stores sell pharmaceuticals, cosmetics, daily necessities, and food products, with additional operations in Thailand.

Key people

Tatsuichi Asada
Independent Director · since 2024
Yasuo Nakayama
Independent Director · since 2025
Takuya Okazaki
Independent Director · since 2021
Hiroshi Okuno
Independent Director · since 2023
Harumi Sato
Independent Director · since 2019
Wakana Tanaka
Independent Director · since 2023
URL
https://www.tsuruha-hd.co.jp/
IPO date
Nov 16, 2005
Employees
11,298
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFYFY
2026‑022025‑052025‑022024‑052023‑052022‑052021‑052020‑052019‑052018‑052017‑05
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT